Randomized Controlled Trial Comparing Continuous Intrajejunal Levodopa Infusion and Deep Brain Stimulation for Parkinson's Disease. Cost-effectiveness and Cost-utility Outcomes of the INVEST Study

被引：0
|
作者：
van Poppelen, D.
van Barreveld, M.
de Bie, R.
Schuurman, P.
van Delft, F.
Geurtsen, G.
de Haan, R.
Dijkgraaf, M.
Dijk, J.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
141
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness and Cost-Utility of Internet-Delivered Exposure Therapy for Fibromyalgia: Results From a Randomized, Controlled Trial
    Hedman-Lagerlof, Maria
    Hedman-Lagerlof, Erik
    Ljotsson, Brjann
    Wicksell, Rikard K.
    Flink, Ida
    Andersson, Erik
    JOURNAL OF PAIN, 2019, 20 (01): : 47 - 59
  • [22] COST ANALYSIS OF DEEP BRAIN STIMULATION, APOMORPHINE INFUSION PUMPS AND CONTINUOUS DUODENAL LEVODOPA-CARBIDOPA INFUSION IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE IN SPAIN: SCOPE STUDY
    Valldeoriola, F.
    Puig-Junoy, J.
    Puig-Peiro, R.
    Gonzalez, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 238 - 238
  • [23] The cost-effectiveness of continuous duodenal delivery of levodopa (Duodopa®) in patients with severe Parkinson's disease
    Kristiansen, IS
    Bingefors, C
    Nyholm, D
    Isacson, D
    MOVEMENT DISORDERS, 2005, 20 : S80 - S80
  • [24] Cost-effectiveness of continuous duodenal delivery of levodopa (Duodopa®) in patients with severe Parkinson's disease
    Kristiansen, IS
    Bingefors, K
    Isacson, D
    VALUE IN HEALTH, 2005, 8 (06) : A133 - A134
  • [25] Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review
    Akhil Sasidharan
    Bhavani Shankara Bagepally
    S Sajith Kumar
    Applied Health Economics and Health Policy, 2024, 22 : 181 - 192
  • [26] Cost Effectiveness of Deep Brain Stimulation for Parkinson's Disease: A Systematic Review
    Sasidharan, Akhil
    Bagepally, Bhavani Shankara
    Kumar, S. Sajith
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2024, 22 (02) : 181 - 192
  • [27] Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis
    Fundament, Tomasz
    Eldridge, Paul R.
    Green, Alexander L.
    Whone, Alan L.
    Taylor, Rod S.
    Williams, Adrian C.
    Schuepbach, W. M. Michael
    PLOS ONE, 2016, 11 (07):
  • [28] COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS INTRADUODENAL LEVODOPA INTESTINAL GEL INFUSION IN THE TREATMENT OF ADVANCED AND SEVERE FORMS OF PARKINSON'S DISEASE
    Kabeshova, A.
    Launois, R.
    VALUE IN HEALTH, 2016, 19 (07) : A425 - A425
  • [29] Deep Brain Stimulation for Advanced Parkinson Disease in Developing Countries: A Cost-Effectiveness Study From China
    Guo, Xinxia
    Feng, Chen
    Pu, Jiali
    Jiang, Hongjie
    Zhu, Zhoule
    Zheng, Zhe
    Zhang, Jianmin
    Chen, Gao
    Zhu, Junming
    Wu, Hemmings
    NEUROSURGERY, 2023, 92 (04) : 812 - 819
  • [30] Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial
    Lowenberg, Mark
    van Barreveld, Marit
    Volkers, Adriaan
    van Gennep, Sara
    Duijvestein, Marjolijn
    van Bodegraven, Adriaan A.
    Hulshoff, Melanie S.
    Jansen, Jeroen M.
    van Asseldonk, Dirk
    West, Rachel
    D'Haens, Geert
    de Boer, Nanne
    Dijkgraaf, Marcel G. W.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024, 12 (09) : 1256 - 1265
12345